BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2021 10:51:03 AM | Browse: 858 | Download: 2938
 |
Received |
|
2021-03-07 17:57 |
|
Peer-Review Started |
|
2021-03-07 18:01 |
|
First Decision by Editorial Office Director |
|
2021-03-27 17:50 |
|
Return for Revision |
|
2021-03-27 17:50 |
|
Revised |
|
2021-04-09 07:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-28 07:54 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-28 08:19 |
|
Articles in Press |
|
2021-04-28 08:19 |
|
Edit the Manuscript by Language Editor |
|
2021-05-10 14:32 |
|
Typeset the Manuscript |
|
2021-06-03 06:01 |
|
Publish the Manuscript Online |
|
2021-06-08 10:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Enhancer of zeste homolog 2 contributes to apoptosis by inactivating JAK2/STAT signaling in inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jie Zhou, Yang Yang, Yi-Ling Wang, Yue Zhao, Wen-Jing Ye, Si-Yao Deng, Jin-Yi Lang and Shun Lu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81900498 |
|
| Corresponding Author |
Shun Lu, MD, Chief Physician, Department of Radiation Oncology, Sichuan Cancer Hospital, No. 55 Renmin South Road, Chengdu 610041, Sichuan Province, China. lushousi90036@163.com |
| Key Words |
Inflammatory bowel disease; Apoptosis; Enhancer of zeste homolog 2; JAK2; Permeability; Inflammatory bowel disease therapy |
| Core Tip |
In this study, we discovered that enhancer of zeste homolog 2 (EZH2) contributed to apoptosis and inflammatory response by inactivating JAK2/STAT signaling in inflammatory bowel disease (IBD). EZH2 may be applied as the potential targets for IBD therapy. |
| Publish Date |
2021-06-08 10:51 |
| Citation |
Zhou J, Yang Y, Wang YL, Zhao Y, Ye WJ, Deng SY, Lang JY, Lu S. Enhancer of zeste homolog 2 contributes to apoptosis by inactivating JAK2/STAT signaling in inflammatory bowel disease. World J Gastroenterol 2021; 27(22): 3073-3084 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i22/3073.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i22.3073 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
